Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akushevich I., Kravchenko J.S., Manton K.G., 2007. Health based population forecasting: effects of smoking on mortality and fertility. Risk Anal, 27(2):467–482.
Akushevich I., Kulminski A., Manton K., 2005. Life tables with covariates: life tables with covariates: dynamic model for nonlinear analysis of longitudinal data. Math Popul Stud 12(2):51–80.
Anderson R.N., 2002. Deaths: leading causes for 2000. Natl Vital Stat Rep 50(16):1–85.
Andreassi M.G., Botto N., Colombo M.G. et al., 2000. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular disease? Environ Mol Mutagen 35:265–269.
Arabi M., Moshtaghi H., 2005. Influence of cigarette smoking on spermatozoa via seminal plasma. Andrologia 37(4):119–124.
Aragona M., Maisano R., Panetta S. et al., 2000. Telomere length maintenance in aging and carcinogenesis. Int J Oncol 17:981–989.
Ardestani S.K., Inserra P., Solkoff D., Watson R.R., 1999. The role of cytokines and chemokines on tumor progression: a review. Cancer Detect Prev 23:215–225.
Aviram M., 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 33(Suppl):S85–S97.
Bakker S.J., Gans R.O., 2000. About the role of shear stress in angiogenesis. Cardiovasc Res 45:270–272.
Banks D.A., Fossel M., 1997. Telomeres, cancer, and aging. Altering the human life span. JAMA 278:1345–1348.
Bartsch H., 2000. Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462:255–279.
Blobe G.C., Schiemann W.P., Lodish H.F., 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358.
Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., Samani N.J., 2003. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23:842–846.
Bruce W.R., Wolever T.M., Giacca A., 2000. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 37:19–26.
Cai H., Harrison D.G., 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844.
CDC (Centers for Disease Control and Prevention), 1997. Smoking-attributable mortality and years of potential life lost – United States, 1984. MMWR Morb Mortal Wkly Rep 46(20):444–451.
CDC (Centers for Disease Control and Prevention), 2005. Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR Morb Mortal Wkly Rep 54(25):625–628.
Cerami C., Founds H., Nicholl I. et al., 1997. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94:13915–13920.
Chambers J.C., Seddon M.D., Shah S., Kooner J.S., 2001. Homocysteine: a novel risk factor for vascular disease J R Soc Med 94:10–13.
Checkoway H., DiFernando G., Hulka B.S., Mickey D.D., 1987. Medical, lifestyle, and occupational risk factors for prostate cancer. Prostate 10:79–88.
Chen J.Z., Zhang F.R., Tao Q.M., Wang X.X., Zhu J.H., 2004. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolemia. Clin Sci (Lond) 107:273–280.
Chisolm G.M., Chai Y., 2000. Regulation of cell growth by oxidized LDL. Free Radic Biol Med 28:1697–1707.
Ciardiello F., 2000. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents. Drugs 60(Suppl 1):25–32.
Clemons M., Goss P., 2001. Estrogen and the risk of breast cancer. N Engl J Med 344:276–285.
Coleman W.B., Tsongalis G.J., 1999. The role of genomic instability in human carcinogenesis. Anticancer Res 19:4645–4664.
Collins T., Cybulsky M.I., 2001. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255–264.
Curran S., Murray G.I., 2000. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 36:1621–1630.
DHHS (U.S. Department of Health and Human Services), 2000. Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health. 2nd edition, Vol. 2. Washington, DC: U.S. Department of Health and Human Services.
DHHS (U.S. Department of Health and Human Services), 2004. The Health Consequences of Smoking. A Report of the Surgeon General U.S. Department of Health and Human Services. Rockville, MD: Public Health Service Office of the Surgeon General. http://www.cdc.gov/tobacco/sgr/sgr_2004/chapters.htm
Dimmeler S., Zeiher A.M., 2000. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434–439.
Djousse L., Myers R.H., Coon H., Arnett D.K., Province M.A., Ellison R.C., 2000. Smoking influences the association between apolipoprotein E and lipids: the National Heart, Lung, and Blood Institute Family Heart Study. Lipids 35(8):827–831.
Doll R., Peto R., Boreham J. et al., 2005. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426–429.
Dorfman S.F., 2008. Tobacco and fertility: our responsibilities. Fertil Steril 89(3):502–504.
Dreyer L., Olsen J.H., 1999. Risk for non-smoking-related cancer in atherosclerotic patients. Cancer Epidemiol, Biomarkers Prev, 8:915–918.
Edelberg J.M., 2002. Auto repair on the aging stem cell superhighway. Sci Aging Knowledge Environ 4 Sept:13. DOI: 10.1126/sageke.2002.35.pe13.
Enstrom J.E., 1984. Smoking and longevity studies. Science 225:878.
Evans W.K., Will B.P., Berthelot J.M., Wolfson M.C., 1995. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. Can J Oncol 5:408–419.
Feinleib M., Luoto J., 1984. Longevity of non-smoking men and women. Public Health Rep 99:223.
Fellows J.L., Trosclair A., Adams E.K., Rivera C.C., 2002. Annual smoking-attributable mortality, years of potential life lost, and economic costs – United States, 1995–1999. Morb Mortal Wkly Rep 51(14):300–303.
Feuer E.J., Etzioni R., Cronin K.A., Mariotto A., 2004. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res 13:421–442.
Flegal K.M., Troiano R.P., Pamuk E.R., Kuczmarski R.J., Cambell S.M., 1995. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 333:1165–1170.
Gajalakshmi G.K., Jha P., Ranson K., Nguyen S., 2000. Global patterns of smoking and smoking-attributable mortality. In: Jha P., Chalouka F. (eds.). Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, pp. 11–40.
George S.J., 2000. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Invest Drugs 9:993–1007.
Gerszten R.E., Mach F., Sauty A. et al., 2000. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 136:87–92.
Gilbert N., Troitszch K.G., 1999. Simulation for the Social Scientist. Buckingham: Open University Press.
Giovino G.A., Schooley M.W., Zhu B.P., Chrismon J.H., Tomar S.L., Peddicord J.P., Merritt R.K., Husten C.G., Erikson M.P., 1994. Surveillance for selected tobacco use behavior – United States, 1900–1994. Morb Mortal Wkly Rep CDC Surveill Summ 43(3):1–43.
GMWKIII, 1998. Deaths from 282 Selected Causes by 5-year Age Groups, Race and Sex: Each State and the District of Columbia, 1995, 1996, 1997 and 1998. National Center for Health Statistics. http://cdc.gov/nchs/data/mortab
Goldschmidt-Clermont P., Peterson E.D., 2003. On the memory of a chronic illness. Sci Aging Knowledge Environ 12 Nov:8. DOI: 10.1126/sageke.2003.45.re8.
Harach H.R., Williams E.D., 1995. Childhood thyroid cancer in England and Wales. Br J Cancer 72:777–783.
Hatzistamou J., Kiaris H., Ergazaki M., Spandidos D.A., 1996. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 225:186–190.
Health, United States, 2002. National Center for Health Statistics, http://www.cdc.gov/nchs/products/pubs/pubd/hus/02hustop.htm
Heart Disease and Stroke Statistics, 2005. Update. (American Heart Association, Dallas, TX), at http://www.americanheart.org/downloadable/heart/1105390918119HDSStats2005Update.pdf
Henderson B.E., Bogdanoff E., Gerkins V.R., SooHoo J., Arthur M., 1974. Evaluation of cancer risk factors in a retirement community. Cancer Res 34:1045–1048.
Hermann M., Berger P., 1999. Hormone replacement in the aging male? Exp Gerontol 34:923–933.
Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T., 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600.
Holden C., 1983. Can smoking explain ultimate gender gap? Science 221:1034.
Hoyert D.L., Anderson R.N., 2001. Age-adjusted death rates: trend data based on the year 2000 standard population. Natl Vital Stat Rep 49(9):1–6.
Human Mortality Database (HMD), 2006. Internet address: http://www.mortality.org
IARC, 1990. Cancer: Causes, Occurrence, and Control. Vol. 100, Lyon, France: IARC Scientific Publications.
IARC, 2004. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. Lyon: International Agency for Research on Cancer.
Irani K., 2000. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87:179–183.
Isner J.M., 1999. Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation 99:1653–1655.
Israels E.D., Israels L.G., 2000. The cell cycle. Oncologist 5:510–513.
Ivanov V.K., Manton K.G., Akushevich I., Gorsky A.I., Korelo A.M., Kravchenko J.S., Maksioutov M.A., Tsyb A.F., 2005. Risk of thyroid cancer after irradiation in children and adults. Curr Oncol 12(2):55–64.
JAMA, 2002. Annual smoking-attributable mortality, years of potential life-lost, and economic costs – United States, 1995–1999. JAMA 287:2355–2356.
Jensen T.K., Joffe M., Scheike T. et al., 2006. Early exposure to smoking and future fecundity among Danish twins. Int J Androl 29(6):603–613.
Jeremy J.Y., Rowe D., Emsley A.M., Newby A.C., 1999. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 43:580–594.
Joesoef M.R., Beral V., Aral S.O., Rolfs R.T., Cramer D.W., 1993. Fertility and use of cigarettes, alcohol, marijuana and cocaine. Ann Epidemiol, ISSN: 1047-2797, 3(6):592–594.
Jump D.B., Clarke S.D., 1999. Regulation of gene expression by dietary fat. Ann Rev Nutr 19:63–90.
Kerbel R.S., 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505–515.
Koohestani N., Chia M.C., Pham N.A., Tran T.T., Minkin S., Wolever T.M., Bruce W.R., 1998. Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy. Carcinogenesis 19:1679–1684.
Koyi H., Branden E., Gnarpe J., Gnarpe H., Arnholm B., Hillerdal G., 1999. Chlamydia pneumonia may be associated with lung cancer. Preliminary report on a seroepidemiological study. APMIS 107(9):828–832.
Kravchenko J., Goldschmidt-Clermont P.J., Powell T., Stallard E., Akushevich I., Cuffe M.S., Manton K.G., 2005. Endothelial progenitor cell therapy for atherosclerosis: the philosopher’s stone for an aging population? Sci Aging Knowledge Environ 2005(25):e18.
Kullo I.J., Gau G.T., Tajik A.J., 2000. Novel risk factors for atherosclerosis. Mayo Clin Proc 75(4):369–380.
Kune G.A., Kune S., Watson L-F., 1988. Colorectal cancer risk, chronic illness, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 48:4399–4404.
Leinonen M., Saikku P., 2000. Infections and atherosclerosis. Scand Cardiovasc J 34:12–20.
Li C., Xu Q., 2000. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 12:435–445.
Lichtenstein P., Holm N.V., Vercasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K., 2000. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85.
Littman A.J., White E., Jackson L.A., Thornquist M.D., Gaydos C.A., Goodman G.E., Vaughan T.L., 2004. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 13:1624–1630.
Manole D., Schildknecht B., Gosnell B., Adams E., DerWahl M., 2001. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86(3):1072–1077.
Manton K.G., Akushevich I., 2003. State variable methods for demographic analysis: a mathematical theory of physiological regeneration and aging. Nonlinear Phenom Complex Syst 6(2):1–15.
Manton K.G., Stallard E., 1988. Chronic disease risk modeling: measurement and evaluation of the risks of chronic disease processes. In the Griffin Series of the Biomathematics of Diseases. London, England: Charles Griffin Limited.
Manton K.G., Stallard E., Singer B.H., 1992. Projecting the future size and health status of the U.S. elderly population. Int J Forecast 8:433–458.
Manton K.G., Stallard E., Woodbury M.A., Dowd J.E., 1994. Time-varying covariates in models of human mortality and aging: Multidimensional generalizations of the Gompertz. J Gerontol 49:B169–B190.
Manton K.G., Yashin A.I., 2000. Mechanisms of Aging and Mortality: Searches for New Paradigms. Odense, Denmark: Odense University Press.
Markle H.V., 1997. Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status. Med Hypotheses 49:282–292.
Marmot M., Elliott P., 2005. Coronary Heart Disease Epidemiology. From Aetiology to Public Health. 2nd edition. New York: Oxford University Press, p. 932.
Marnett L.J., 2000. Oxyradicals and DNA damage. Carcinogenesis 21:361–370.
Martin J.A., Hamilton B.E., Ventura S.J., 2001. Births: preliminary data for 2000. Natl Vital Stat Rep. 49(5):1–20.
Martin J.A., Hamilton B.E., Ventura S.J., Menacker F., Park M.M., Sutton P.D., 2002b. Births: final data for 2001. Natl Vital Stat Rep 51(2):1–102.
Martin J.A., Park M.M., Sutton P.D., 2002a. Births: preliminary data for 2001. Natl Vital Stat Rep 50(10):1–20.
Maxwell S.R., 1998. Women and heart disease. Basic Res Cardiol 93(Suppl 2):79–84.
Mayo M.W., Baldwin A.S., 2000. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470:M55–M62.
McCully K.S., 1994. Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism. Ann Clin Lab Sci 24:27–59.
Miller G.H., Gerstein D.R., 1983. The life expectancy of non-smoking men and women. Public Health Rep 98:343–349.
Minino A.M., Arias E., Kochanek K.D., Murphy S.L., Smith B.L., 2002. Deaths: final data for 2000. Natl Vital Stat Rep 50(15):1–119.
Misra A., 2000. Risk factors for atherosclerosis in young individuals. J Cardiovasc Risk 7:215–229.
MMWR, 2005. Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR 54(25):625–628.
MMWR, 2006. Tobacco use among adults – United States, 2005. MMWR 55(42):1145–1148.
Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.I., 2004. Actual causes of death in the United States, 2000. JAMA 291(10):1238–1245.
Molarius A., Seidell J.C., Kuulasmaa K., Dobson A.J., Sans S., 1997. Smoking and relative body weight: an international perspective from the WHO MONICA project. J Epidemiol Community Health 51:252–260.
Moore M.A., Tsuda H., 1998. Chronically elevated proliferation as a risk factor for neoplasia. Eur J Cancer Prev 7:353–385.
Morre S.A., Stooker W., Lagrand W.K. et al., 2000. Microorganisms in the etiology of atherosclerosis. J Clin Pathol 53:647–654.
Mostafa T., Tawadrous G., Roaia M.M. et al., 2006. Effect of smoking on seminal plasma ascorbic acid in infertile and fertile males. Andrologia 38(6):221–224.
Neugut A.I., Jacobson J.S., Ghada S., Sherif G., Ahsan H., Garbowski G.C., Waye J., Forde K.A., Treat M.R., 1995. Coronary artery disease and colorectal neoplasia. Dis Colon Rectum 38:873–877.
Neugut A.I., Rosenberg D.J., Ahsan H., Jakobson J.S., Wahid N., Hagan M., Rahman M.I., Khan Z.R., Chen L., Pablos-Mendez A., Shea S., 1998. Association between coronary heart disease and cancers of the breast, prostate, and colon cancer. Cancer Epidemiol Biomarkers Prev 7:869–873.
Newby A.C., Zaltsman A.B., 2000. Molecular mechanisms in intimal hyperplasia. J Pathol 190:300–309.
Niho N., Takahashi M., Kitamura T., Shoji Y., Itoh M., Noda T., Sugimura T., Wakabayashi K., 2003a. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferators-activated receptor ligands. Cancer Res 63:6090–6095.
Niho N., Takahashi M., Shoji Y., Takeuchi Y., Matsubara S., Sugimura T., Wakabayashi K., 2003b. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. Cancer Sci 94:960–964.
Nugent M.A., Iozzo R.V., 2000. Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115–120.
O’Brien E.R., Urieli-Shoval S., Garvin M.R. et al., 2000. Replication in restenotic atherectomy tissue. Atherosclerosis 152:117–126.
O’Hara P., Connett J.E., Lee W.W., Nides M., Murray R., Wise R., 1998. Early and late weight gain following smoking cessation in the lung health study. Am J Epidemiol 148:821–830.
Okura Y., Brink M., Itabe H. et al., 2000. Oxidized low-density lipoproteins is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation 102:2680–2686.
Parsons R., Myeroff L.L., Liu B. et al., 1995. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550.
Peate I., 2005. The effects of smoking on the reproductive health of men. Br J Nurs 14(7):362–366.
Pekkanen J., Manton K.G., Stallard E., Nissinen A., Karvonen M.J., 1992. Risk factor dynamics, mortality, and life expectancy differences between eastern and western Finland: the Finnish cohorts of the seven countries study. Int J Epidemiol 21:406–419.
Powles J.W., Sanz M.A., 1996. Vascular mortality not attributable to smoking trends in European populations since the 1950s. In: The XIV International Scientific Meeting of the International Epidemiological Association: global health in a changing environment. Program and abstracts. Nagoya: International Epidemiological Association, p. 189.
Ramlau-Hansen C.H., Thulstrup A.M., Aggerholm A.S. et al., 2007. Is smoking a risk factor for decreased semen quality? A cross-sectional analysis. Hum Reprod 22(1):188–196.
Ramsey S.D., McIntosh M., Etzioni R., Urban N., 2000. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am 14(4):925–938.
Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., Pippen A.M., Annex B.H., Dong C., Taylor D.A., 2003. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 29, 457–463.
Reed J.C., 2000. Apoptosis and cancer: strategies for integrating programmed cell death. Semin Hematol 37(Suppl 7):9–16.
Robbins W.A., Elashoff D.A., Xun L., Jia J., Li N., Wu G., Wei F., 2005. Effect of lifestyle exposures on sperm aneuploidy. Cytogenet Genome Res 111(3–4):371–377.
Rodu B., Stegmayr B., Nasic S., Cole P., Asplund K., 2004. The influence of smoking and smokeless tobacco use on weight amongst men. J Intern Med 255:102–107.
Ron E., Kleinerman R.A., Boice J.D., LiVolsi V.A., Flannery J.T., Fraumen J.F., 1987. A population-based case–control study of thyroid cancer. J Natl Cancer Inst 79:1–12.
Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., Ginsburg G.S., 2001. Atherosclerosis and cancer. Common molecular pathways of disease development and progression. Ann NY Acad Sci 947:271–293.
Ruef J., Peter K., Nordt T.K. et al., 1999. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 82:32–37.
Sasayama S., Okada M., Matsumori A., 2000. Chemokines and cardiovascular diseases. Cardiovasc Res 45:267–269.
Schwartz S.M., Murry C.W., 1998. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49:437–460.
Sempos C.T., Durazo-Arvizu R., McGee D.L., Cooper R.S., Prewitt T.E., 1998. The influence of cigarette smoking on the association between body weight and mortality. The Framingham Heart Study revisited. Ann Epidemiol 8(5):289–300.
Sepaniak S., Forges T., Monnier-Barbarino P., 2005. Consequences of cigarette smoking on male fertility. J Gynecol Obstet Biol Reprod (Paris) 34(1):3S102–3S111.
Sepaniak S., Forges T., Monnier-Barbarino P., 2006. Cigarette smoking and fertility in women and men. Gynecol Obstet Fertil 34(10):945–949.
Shackelford R.E., Kaufmann W.K., Paules R.S., 2000. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28:1387–1404.
Shi L., Macinko J., Starfield B., Politzer R., Xu J., 2005. Primary care, race, and mortality in U.S. States. Soc Sci Med 61(1):65–75.
Slater S., Oliver R.T., 2000. Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy. Drugs Aging 17:431–439.
Smith R.A., Glynn T.J., 2000. Epidemiology of lung cancer. Radiol Clin North Am 38:453–470.
Smoking and Tobacco Control Monograph, 1997. No. 6, NIH Pub. No. 97-4213.
Strong J.P, Malcom G.T., McMahan C.A., Tracy R.E., Newman III W.P., Herderick E.E., Cornhill J.F., 1999. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281:727–735.
Tabuchi M., Kitayama J., Nagawa H., 2006. Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 12(8):1261–1264.
Tardif J.C., 2000. Insights into oxidative stress and atherosclerosis. Can J Cardiol 16(Suppl):2D–4D.
Thambyrajah J., Townsend J.N., 2000. Homocysteine and atherothrombosis: mechanisms for injury. Eur Heart J 21:967–974.
Thompson M.M., Garland C., Barrett E., Khaw K., Friedlander N.J., Wingard D.L., 1988. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 129:511–517.
TIPS (Tobacco Information and Prevention Source), November 2005. Smoking Prevalence Among U.S. Adults. URL: http//www.cdc.gov/tobacco/research_data/adults_prev/prevail.htm
Tunstall-Pedoe H. (ed.), 2003. Monica: Monograph and Multimedia Sourcebook. Geneva, Switzerland: World Health Organization.
Tzonou A., Hsich C.-C., Trichopoulos D., Aravandinos D., Kalandidi A., Margaris D., Goldman M., Toupadaki N., 1993. Induced abortions, miscarriages and tobacco smoking as risk factors for secondary infertility. J Epidemiol Community Health 47:36–39.
Vainio H., Bianchini F., 2002. IARC Handbooks of Cancer Prevention. Vol. 6: Weight Control and Physical Activity. Lyon, France: IARC Press.
Van den Akker-van Marle M.E., van Ballegooijen M., van Oortmarssen G.J., Boer R., Habbema J.D., 2002. Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst 94:193–204.
Vanness D.J., Tosteson A.N., Gabriel S.E., Melton L.J., 2005. The need for microsimulation to evaluate osteoporosis interventions. Osteoporos Int 16(4):353–358.
Ventura S.J., Hamilton B.E., Sutton P.D., 2003. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 51(4):1–18.
Waldron I., 1986. The contribution of smoking to sex differences in mortality. Public Health Rep 101(2):163–173.
Wallenfeldt K., Hulthe J., Bokemark L., Wikstrand J., Fagerberg B., 2001. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58 year old men. J Intern Med 250:492–501.
Wang X.L., 2000. Cigarette smoking. DNA variants in endothelial nitric oxide synthase gene and vascular disease. Contrib Nephrol 130:53–67.
Wang J.M., Deng X., Gong W., Su S., 1998. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220:1–17.
Witteman J.C.M., Grobbee D.E., Valkenburg H.A., van Hemert A.M., Stijnen T., Burger H., Hofman A., 1994. J-shaped relation between change in diastolic blood pressure and aortic atherosclerosis. Lancet 343:504–507.
Wolf D., 2001. The role of microsimulation in longitudinal data analysis. Can Stud Popul 28:165–179.
Wolfson M.C., 1994. POHEM – a framework for understanding and modeling the health of human populations. World Health Stat Q 47:157–176.
Wood D., 2001. Established and emerging cardiovascular risk factors. Am Heart J 141:49–57.
Woodbury M.A., Manton K.G., 1977. A random walk model of human mortality and aging. Theor Popul Biol 11:37–48.
Woodbury M.A., Manton K.G., 1983a. A mathematical model of the physiological dynamics of aging and correlated mortality selection. I. Theoretical development and critiques. J Gerontol 38:398–405.
Woodbury M.A., Manton K.G., 1983b. A theoretical model of the physiological dynamics of circulatory disease in human populations. Human Biol 55:417–441.
Woodbury M.A., Manton K.G., Stallard E., 1981. Longitudinal models for chronic disease risk: an evaluation of logistic multiple regression and alternatives. Int J Epidemiol 10:187–197.
Yamada K., Araki S., Tamura M., Sakai I., Takahashi Y., Kashihara H., Kono S., 1998. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27:794–798.
Yancopoulos G.D., Davis S., Gale N.W. et al., 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242–248.
Zalba G., Beaumont J., San Jose G. et al., 2000. Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem 56:57–64.
Zettler M.E., Pierce G.N., 2000a. Cell cycle proteins and atherosclerosis. Herz 25:100–107.
Zettler M.E., Pierce G.N., 2000b. Growth-promoting effects of oxidized low density lipoprotein. Can J Cardiol 17:73–79.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Manton, K., Akushevich, I., Kravchenko, J. (2009). Risk Factors Intervention. In: Cancer Mortality and Morbidity Patterns in the U.S. Population. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78193-8_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-78193-8_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78192-1
Online ISBN: 978-0-387-78193-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)